Search - tctmd.com

Displaying 281 - 300 of 1170

Sort: Relevancy | Date

News Daily News

More Women Than Men Develop HF or Die After STEMI

L.A. McKeown

December 01, 2020

News Daily News

CAC Testing Improves Pretest Probability of Obstructive CAD

Michael O'Riordan

November 23, 2020

News Daily News

Type 2 MI Patients Often Miss Out on Seeing a Cardiologist

Caitlin E. Cox

November 23, 2020

News Daily News

FDA Grants Stroke Prevention Indication to Ticagrelor

Shelley Wood

November 06, 2020

News Daily News

Bleeds on Anticoagulants for A-Fib Can Unveil Occult Cancers

Caitlin E. Cox

November 06, 2020

News Daily News

H. Pylori in ACS: Could Tests and Treatment Beat Back the Bleeds?

Shelley Wood

November 05, 2020

News Daily News

Fewer MIs With Prasugrel Than Ticagrelor in STEMI Patients: ISAR-REACT 5

Michael O'Riordan

November 03, 2020

News Daily News

Superiority of Ticagrelor Over Clopidogrel in ACS Questioned

Todd Neale

October 29, 2020

News Daily News

Failure to Access Coronaries After TAVR Almost Exclusive to CoreValve Evolut

Michael O'Riordan

October 28, 2020

News Daily News

More Circulating Omega-3s May Boost Prognosis After STEMI

Todd Neale

October 26, 2020

News Daily News

More Risk of Death—All, Cardiac, and Noncardiac—With PCI Over Surgery: Meta-analysis

Michael O'Riordan

October 23, 2020

News Daily News

Study Affirms Thrombotic Risk in COVID-19

Todd Neale

October 01, 2020

News Daily News

Even in Ideal Patients, Surgeons Aren’t Doing Multiarterial CABG

Shelley Wood

September 28, 2020

News Daily News

VERTIS CV: Ertugliflozin Meets Noninferiority Endpoint but Misses Other Marks

Michael O'Riordan

September 24, 2020

News Daily News

Clopidogrel Only Needed for 3 Months After ASD Closure: CANOA Analysis

Caitlin E. Cox

September 23, 2020

News Daily News

Hostility After ACS Linked to All-Cause Mortality

Michael O'Riordan

September 21, 2020

News Daily News

Colchicine Shows Potential in Malignant Pericardial Effusion

Caitlin E. Cox

September 21, 2020

News Daily News

‘Aspirin-Free’ Antiplatelet Strategy Feasible After PCI, Pilot Study Suggests

Michael O'Riordan

September 18, 2020

News Daily News

‘Speaking the Same Language’: New Guidance for Trials of Patients at High Bleeding Risk

Michael O'Riordan

September 16, 2020

News Daily News

LDL Cholesterol Control Post-PCI Is Low and Linked to Worse Outcomes

Yael L. Maxwell

September 14, 2020

Advertisement

More Women Than Men Develop HF or Die After STEMI

CAC Testing Improves Pretest Probability of Obstructive CAD

Type 2 MI Patients Often Miss Out on Seeing a Cardiologist

FDA Grants Stroke Prevention Indication to Ticagrelor

Bleeds on Anticoagulants for A-Fib Can Unveil Occult Cancers

H. Pylori in ACS: Could Tests and Treatment Beat Back the Bleeds?

Fewer MIs With Prasugrel Than Ticagrelor in STEMI Patients: ISAR-REACT 5

Superiority of Ticagrelor Over Clopidogrel in ACS Questioned

Failure to Access Coronaries After TAVR Almost Exclusive to CoreValve Evolut

More Circulating Omega-3s May Boost Prognosis After STEMI

More Risk of Death—All, Cardiac, and Noncardiac—With PCI Over Surgery: Meta-analysis

Study Affirms Thrombotic Risk in COVID-19

Even in Ideal Patients, Surgeons Aren’t Doing Multiarterial CABG

VERTIS CV: Ertugliflozin Meets Noninferiority Endpoint but Misses Other Marks

Clopidogrel Only Needed for 3 Months After ASD Closure: CANOA Analysis

Hostility After ACS Linked to All-Cause Mortality

Colchicine Shows Potential in Malignant Pericardial Effusion

‘Aspirin-Free’ Antiplatelet Strategy Feasible After PCI, Pilot Study Suggests

‘Speaking the Same Language’: New Guidance for Trials of Patients at High Bleeding Risk

LDL Cholesterol Control Post-PCI Is Low and Linked to Worse Outcomes

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content